Reveal LINQ Respiration Clinical Study

Completed

Conditions studied: Respiratory Rate

In brief

The LINQ™ Respiration study will collect and characterize Reveal LINQ™ derived respiration data from patients undergoing a simulated 24-hour time period while being monitored with capnography.

Key facts

Study ID: NCT04506684
Run by: Medtronic Cardiac Rhythm and Heart Failure
People needed: 79
Starts: 2020-09-25
Expected to finish: 2021-07-31
Last updated by the study team: 2023-12-18

Who can join

Age: 55 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

Patient is ≥ 55 years old
Patient (or patient's legally authorized representative) is willing and able to provide written informed consent
Patient is willing and able to comply with the study procedures
Patient has an active Medtronic Reveal LINQ device that has been implanted for ≥ 60 days and no more than 3 years

You may not qualify if…

Patient has an existing condition that necessitates the use of supplemental oxygen
Patient has an active acute respiratory infection or a respiratory disorder that may affect ability to perform respiratory maneuvers
Patient has NYHA Class IV heart failure per most recent assessment
Any concomitant condition that might endanger the patient through participation in the study or interfere with study procedures, as assessed by the investigator
Patient is enrolled in another study that could confound the results of this study
Patient has an existing implantation of Medtronic IPG, ICD, CRT-D or CRT-P device

Where it is running

Cardiac Arrhythmia Service — Boca Raton, Florida, United States
CentraCare Heart & Vascular Center — Saint Cloud, Minnesota, United States
Oklahoma Heart Hospital Research Foundation — Oklahoma City, Oklahoma, United States
The Stern Cardiovascular Foundation — Germantown, Tennessee, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.